Terms: = Brain cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Diagnosis
49 results:
1. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Ercan AB; Aronson M; Fernandez NR; Chang Y; Levine A; Liu ZA; Negm L; Edwards M; Bianchi V; Stengs L; Chung J; Al-Battashi A; Reschke A; Lion A; Ahmad A; Lassaletta A; Reddy AT; Al-Darraji AF; Shah AC; Van Damme A; Bendel A; Rashid A; Margol AS; Kelly BL; Pencheva B; Heald B; Lemieux-Anglin B; Crooks B; Koschmann C; Gilpin C; Porter CC; Gass D; Samuel D; Ziegler DS; Blumenthal DT; Kuo DJ; Hamideh D; Basel D; Khuong-Quang DA; Stearns D; Opocher E; Carceller F; Baris Feldman H; Toledano H; Winer I; Scheers I; Fedorakova I; Su JM; Vengoechea J; Sterba J; Knipstein J; Hansford JR; Gonzales-Santos JR; Bhatia K; Bielamowicz KJ; Minhas K; Nichols KE; Cole KA; Penney L; Hjort MA; Sabel M; Gil-da-Costa MJ; Murray MJ; Miller M; Blundell ML; Massimino M; Al-Hussaini M; Al-Jadiry MF; Comito MA; Osborn M; Link MP; Zapotocky M; Ghalibafian M; Shaheen N; Mushtaq N; Waespe N; Hijiya N; Fuentes-Bolanos N; Ahmad O; Chamdine O; Roy P; Pichurin PN; Nyman P; Pearlman R; Auer RC; Sukumaran RK; Kebudi R; Dvir R; Raphael R; Elhasid R; McGee RB; Chami R; Noss R; Tanaka R; Raskin S; Sen S; Lindhorst S; Perreault S; Caspi S; Riaz S; Constantini S; Albert S; Chaleff S; Bielack S; Chiaravalli S; Cramer SL; Roy S; Cahn S; Penna S; Hamid SA; Ghafoor T; Imam U; Larouche V; Magimairajan Issai V; Foulkes WD; Lee YY; Nathan PC; Maruvka YE; Greer MC; Durno C; Shlien A; Ertl-Wagner B; Villani A; Malkin D; Hawkins C; Bouffet E; Das A; Tabori U
Lancet Oncol; 2024 May; 25(5):668-682. PubMed ID: 38552658
[TBL] [Abstract] [Full Text] [Related]
2. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
3. Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats brain Metastases.
Kieliszek AM; Mobilio D; Upreti D; Bloemberg D; Escudero L; Kwiecien JM; Alizada Z; Zhai K; Ang P; Chafe SC; Vora P; Venugopal C; Singh SK
Clin Cancer Res; 2024 Feb; 30(3):554-563. PubMed ID: 37787999
[TBL] [Abstract] [Full Text] [Related]
4. Recent advances in the diagnosis and the treatment of primary CNS lymphoma.
Rachdi A; Hernandez-Tost H; Herzi D; Morales-Martinez A; Hernández-Verdin I; Houillier C; Alentorn A; Hoang-Xuan K
Rev Neurol (Paris); 2023 Jun; 179(5):481-489. PubMed ID: 37045615
[TBL] [Abstract] [Full Text] [Related]
5. car t-cell therapy in BOlogNa-NEUrotoxicity TReatment and Assessment in Lymphoma (carBON-NEUTRAL): proposed protocol and results from an Italian study.
Pensato U; Amore G; Muccioli L; Sammali S; Rondelli F; Rinaldi R; D'Angelo R; Nicodemo M; Mondini S; Sambati L; Asioli GM; Rossi S; Santoro R; Cretella L; Ferrari S; Spinardi L; Faccioli L; Fanti S; Paccagnella A; Pierucci E; Casadei B; Pellegrini C; Zinzani PL; Bonafè M; Cortelli P; Bonifazi F; Guarino M
J Neurol; 2023 May; 270(5):2659-2673. PubMed ID: 36869888
[TBL] [Abstract] [Full Text] [Related]
6. An adolescent case of sellar osteochondromyxoma in the setting of spondyloepiphyseal dysplasia.
Peng S; Behbahani M; Sharma S; Wadhwani NR; Rastatter JC; Alden TD
Childs Nerv Syst; 2023 Apr; 39(4):1083-1087. PubMed ID: 36723686
[TBL] [Abstract] [Full Text] [Related]
7. Immunotherapy for Pediatric brain and Spine Tumors: Current State and Future Directions.
Estevez-Ordonez D; Gary SE; Atchley TJ; Maleknia PD; George JA; Laskay NMB; Gross EG; Devulapalli RK; Johnston JM
Pediatr Neurosurg; 2023; 58(5):313-336. PubMed ID: 36549282
[TBL] [Abstract] [Full Text] [Related]
8. Primary CNS lymphoma: update on molecular pathogenesis and therapy.
Mo SS; Cleveland J; Rubenstein JL
Leuk Lymphoma; 2023 Jan; 64(1):57-65. PubMed ID: 36286546
[TBL] [Abstract] [Full Text] [Related]
9. Immunotherapy approaches for the treatment of diffuse midline gliomas.
Bernstock JD; Hoffman SE; Kappel AD; Valdes PA; Essayed W; Klinger NV; Kang KD; Totsch SK; Olsen HE; Schlappi CW; Filipski K; Gessler FA; Baird L; Filbin MG; Hashizume R; Becher OJ; Friedman GK
Oncoimmunology; 2022; 11(1):2124058. PubMed ID: 36185807
[TBL] [Abstract] [Full Text] [Related]
10. Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think-aloud study.
Jallow M; Black G; van Os S; Baldwin DR; Brain KE; Donnelly M; Janes SM; Kurtidu C; McCutchan G; Robb KA; Ruparel M; Quaife SL
Health Expect; 2022 Aug; 25(4):1776-1788. PubMed ID: 35475542
[TBL] [Abstract] [Full Text] [Related]
11. Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments.
Soler DC; Kerstetter-Fogle A; McCormick TS; Sloan AE
J Neurooncol; 2022 Jan; 156(1):81-96. PubMed ID: 34825292
[TBL] [Abstract] [Full Text] [Related]
12. carney complex: left atrial myxoma in a patient with past pituitary microadenoma and lentiginosis.
Spindel J; Mathbout MF; Huffman T; Ghafghazi S
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34167977
[TBL] [Abstract] [Full Text] [Related]
13. Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.
Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
Cancer Med; 2021 Aug; 10(15):5019-5030. PubMed ID: 34145792
[TBL] [Abstract] [Full Text] [Related]
14. Allogeneic Natural Killer and Cytomegalovirus (CMV)-pp65 Pulsed Dendritic Cells Induced Complete Response Through 15 Months in a Patient with Recurrent Glioblastoma: A Case Study.
Gumrukcu S; Nguyen TX; White RL; Howell GT; Musikanth P
Am J Case Rep; 2021 Mar; 22():e931030. PubMed ID: 33788825
[TBL] [Abstract] [Full Text] [Related]
15. Neurological complications of chimeric antigen receptor T cells and immune-checkpoint inhibitors: ongoing challenges in daily practice.
Berzero G; Picca A; Psimaras D
Curr Opin Oncol; 2020 Nov; 32(6):603-612. PubMed ID: 32852312
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical and genetic studies of a three-member familial isolated pituitary adenoma with homogeneous prolactinomas].
Vacchiano V; Seleme S; Daly AF; Beckers A; Valdés-Socin H
Medicina (B Aires); 2020; 80(2):181-184. PubMed ID: 32282328
[TBL] [Abstract] [Full Text] [Related]
17. Pituitary tumours in MEN1 syndrome - the new insight into the diagnosis and treatment.
Rogoziński D; Gilis-Januszewska A; Skalniak A; Kluczyński Ł; Pantofliński J; Hubalewska-Dydejczyk A
Endokrynol Pol; 2019; 70(5):445-452. PubMed ID: 31681967
[TBL] [Abstract] [Full Text] [Related]
18. Cognitive functioning and predictors thereof in patients with 1-10 brain metastases selected for stereotactic radiosurgery.
Schimmel WCM; Gehring K; Hanssens PEJ; Sitskoorn MM
J Neurooncol; 2019 Nov; 145(2):265-276. PubMed ID: 31552588
[TBL] [Abstract] [Full Text] [Related]
19. HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Ahmed N; Brawley V; Hegde M; Bielamowicz K; Kalra M; Landi D; Robertson C; Gray TL; Diouf O; Wakefield A; Ghazi A; Gerken C; Yi Z; Ashoori A; Wu MF; Liu H; Rooney C; Dotti G; Gee A; Su J; Kew Y; Baskin D; Zhang YJ; New P; Grilley B; Stojakovic M; Hicks J; Powell SZ; Brenner MK; Heslop HE; Grossman R; Wels WS; Gottschalk S
JAMA Oncol; 2017 Aug; 3(8):1094-1101. PubMed ID: 28426845
[TBL] [Abstract] [Full Text] [Related]
20. The typical and atypical MR imaging findings of central neurocytomas: Report on eighteen cases and review of the literature.
Ma Z; Yan H; Shi H; Li Y; Song J; Huang J; Hong X
Clin Neurol Neurosurg; 2016 Jul; 146():18-23. PubMed ID: 27132079
[TBL] [Abstract] [Full Text] [Related]
[Next]